🔗 Share this article

As America proceeds with unprecedented changes to its vaccination recommendations, a particular individual has surfaced in a surprising turn: Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who rose to prominence by questioning COVID-19 shots during the pandemic and has focused upon possible deaths after COVID-19 immunization in her brief tenure at the US Food and Drug Administration (FDA).

Scheduled Shifts to Pediatric Vaccine Schedule

Health officials planned to unveil radical changes to the childhood vaccine schedule recently, bringing the US with the Danish national calendar, according to reports – a significant shift that would put the US out of step with much of the international standard with no evidence for public health gain. This reveal has been postponed until the next year.

Rather than the director of the vaccine center, Dr. Høeg is listed to speak at the event. She was just designated acting director of the FDA’s CDER, the fifth appointee to head the division this calendar year.

A Shift at the Agency

The acting appointment may indicate a tighter collaboration between the pharmaceutical and vaccine centers as Høeg and Dr. Prasad consolidate power at the regulatory agency – and it suggests a greater focus upon dismantling previously authorized immunizations at the FDA.

The new acting director has frequently advocated for discontinuing some pediatric immunization guidelines in the US to become more similar to Denmark's approach, a nation with comprehensive healthcare and a citizenry about the population of the state of Wisconsin.

To date comments, she has continued to focus on vaccination policy – typically the purview of Prasad, chief of the FDA’s vaccine center – as opposed to medication approval.

Concerns Over Background

Dr. Høeg has no apparent experience in drug development, oversight or administrative roles, which has been standard for previous heads of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a top consultant to the agency head and the vaccine center since spring.

“She doesn’t seem to have the necessary background” for leading the CDER, said Dr. Jonathan Howard. “She has not conducted a scientific study. She lacks experience in leading a sizeable institution. She is not an expert in industry regulation.”

Former commissioners of CBER would “grasp laws and regulations and the science of drug development”, said Janet Woodcock. “Clearly, she lacks the sort of resume that former directors who ran the center have had.”

The drug center has an vast workload at the agency, Woodcock stated.

“The public just pays attention on the new drug program, but the off-patent medication office approves numerous off-brand pharmaceuticals. There is also a biosimilars division, non-prescription drug unit and more, and every single one need to be supervised,” she said. “The responsibility you overlook, that is the part that I always told people is going to bite you.”

There is also, a significant leadership component to the job, which supervises over 5,000 personnel. “It’s a huge management job, if you perform it correctly,” the former official added.

Agency Reaction and Disputed Initiatives

When asked about questions about Høeg’s qualifications and whether this appointment indicates more teamwork among FDA leaders on immunizations, a representative said that the “concerns rely on incorrect assumptions”.

“Her experience matches the responsibilities of her role,” the spokesperson said, pointing to the time Dr. Høeg spent guiding the agency head on “medication safety and approval science, including computational safety modeling and immunization monitoring”.

As the temporary head, Dr. Høeg takes over the commissioner’s recently launched fast-track approval initiative, a contentious rapid drug-approval program that allegedly concerned her preceding directors. “By what process are these medications being picked for this fast-track system? Who takes the choices?” Dr. Howard questioned. “There’s a lot of lack of transparency going on at the regulatory body right now.”

Overall, he said, “the Food and Drug Administration seems to be moving towards less stringent regulations of pharmaceuticals, aside from shots.”

Documented History on Vaccines

Regarding vaccines, Høeg has a more documented, if troubling, history, Howard said. She authored a research paper using non-validated public submissions to assess the rate of myocarditis following Covid immunization. She counseled the Florida top health official Joseph Ladapo, who allegedly have changed statistics to imply COVID-19 vaccinations are more dangerous than they are.

Part of her “desired changes” for the incoming administration included revising regulations for novel immunizations and discontinuing “non-essential” immunizations, she stated post-election on a audio program. At the agency, Høeg has according to sources proposed excluding young men from obtaining Covid vaccinations.

“She’s an thorough true believer who starts off with her conclusions and works backwards to retrofit the science in a very misleading, untruthful fashion,” Dr. Howard stated.

Taking Control and a “Campaign of Retribution”

Høeg aligned with other dissenters, {like|